According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -2,62ย โฌ. In 2021 the company made an earnings per share (EPS) of -2,39ย โฌ an increase over its 2020 EPS that were of -3,84ย โฌ.